ClinicalTrials.gg
Not yet recruitingNCT06813001Updated Feb 6, 2025

ACT-Based Nursing Intervention for Ovarian Cancer Patients: A Pilot Study

An interventional study of ACT-based nursing intervention in Ovarian Neoplasm ; Psychological Distress, sponsored by Yonsei University. Not yet recruiting. Open to female participants aged 19 Years to 75 Years. Per ClinicalTrials.gov, last updated 2025-02-06.

Sponsored by Yonsei University · Not applicable, Interventional, and Other

How we know

From the registry’s dates

  • Primary completion was expected by Jun 2025, 1 year 5 months ago, but the record still lists the study as not yet recruiting.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
25
Allocation
Randomized
Ages
19 Years to 75 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 14 studies in Ovarian Neoplasms by Yonsei University — 4 open to participants now, 6 under way, none of them phase 3. Ovarian Neoplasms · Yonsei University.

Started
2025
the only one that year
No phase
2 of 14
1 open now
Registered
12th of 14
by date

Among the 14 studies in Ovarian Neoplasms by Yonsei University, this one is the only one that started in 2025, is one of 2 with no phase, and was the 12th registered.

Ovarian Neoplasms

3,390 studies on the registry are indexed under Ovarian Neoplasms; 790 are open to participants now.

Browse Ovarian Neoplasms studies →

Open to participants now

4 of the 14 studies in Ovarian Neoplasms by Yonsei University are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 4 open studies →

Who these studies take

Of the 603 Ovarian Neoplasms studies recruiting now, 438 (73%) set no upper age limit and 108 (18%) stop at 75 or younger; 39 take children under 18; 46 take healthy volunteers.

This study: 19 Years to 75 Years · female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 14 studies in Ovarian Neoplasms by Yonsei University, or all of them as a file.
02

Study summary

The purpose of this study is to evaluate the feasiblity and effectiveness of an Acceptance and Commitment Therapy (ACT)-based nursing intervention aimed at managing psychological flexibility, distress, anxiety, depression, fear of cancer recurrence/progression, quality of life, and symptoms. Patients will participate in a single online session with a nurse, followed by a daily self-monitoring survey online for one week. Data will be collected at baseline (prior to the ACT session), on day 8 (after one week of self-monitoring), and at 5 weeks. Primary outcome is psychological flexibility.

Read the detailed description

This study is a preliminary single-group pre-post design aimed at developing and evaluating the feasibility of an ACT-based nursing intervention for distress management in patients with ovarian cancer. A total of 25 ovarian cancer patients who consent to participate will be enrolled in the study. Paticipants will receive a one-time ACT-based nursing intervention lasting approximately 60 minutes.

The researcher will coordinate schedules with participants to deliver the ACT-based nursing intervention using Zoom, a video conferencing platform which minimizes time and location constraints. Before the intervention, the research will ensure that the participants' video conferencing is working properly to minimize potential difficulties during the session.

Following the single-session intervention, the researcher will send a daily Google Form link to participants for seven consecutive days. Participants will be encouraged to access the link and complete self-monitoring surveys to reinforce the key components addressed in the program.

03

Conditions studied

  • Ovarian Neoplasm ; Psychological Distress

Browse trials for

Keywords

  • Ovarian Neoplasms
  • Psychological Distress
  • Acceptand and Commitment Therapy (ACT)
  • Nursing intervention
04

Who can participate

Ages eligible
19 Years to 75 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • adult (19 ≤ age ≤ 75).
  • ovarian cancer patients with FIGO stage 2-3.
  • Those who have completed chemotherapy for ovarian cancer (excluding maintenance therapy) within the past 2 years.

Exclusion criteria

Exclusion Criteria:

  • Patients with cognitive problems such as dementia or psychiatric problems such as major depression or generalized anxiety, or who are actively receiving treatment for any of these conditions.
  • Patients with history of cancer recurrence.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Line of therapy

A line of therapy is one course of treatment, which may combine several drugs. First-line is the first course given; second-line follows when that stops working or is not tolerated.

“Two prior lines” means two courses that count separately under the study’s rules — not simply two drugs. Ask the study team if you are unsure how yours are counted.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Single group
Masking
None (open label)
Enrollment
25 participants (estimated)

Study arms

  • Experimental
    A

    Experimental group with application of ACT-based nursing intervention

    Other: ACT-based nursing intervention

Interventions

  • OtherACT-based nursing intervention

    ACT-based nursing intervention is a 1:1 single online session with a nurse, which takes about 60 minutes followed by a daily self-monitoring survey for one week, which encourages patients to practice ACT.

06

What researchers measure

Primary outcomes

  1. Change from baseline psychological distress on the last day of self-monitoring (Day 8)

    Psychological distress measured by Distress Thermometer.

    Time frame: Psychological distress will be assessed at baseline and on the last day of self-monitoring (Day 8).

Secondary outcomes

  1. Change from baseline depression

    depression measured by the Hospital Anxiety and Depression Scale (HADS).

    Time frame: within 3 weeks after the last day of self-monitoring (window: 7 days)

  2. Change from anxiety

    Anxiety by the Hospital Anxiety and Depression Scale (HADS).

    Time frame: within 3 weeks after the last day of self-monitoring (window: 7 days)

  3. Change from fear of cancer recurrence

    Fear of cancer recurrence measured by the Fear of Cancer Recurrence Index (FCRI).

    Time frame: within 3 weeks after the last day of self-monitoring (window: 7 days)

  4. Change from psychological flexibility

    Psychological flexibility measured by the Acceptance and Action Questionnaire-II (AAQ-II).

    Time frame: within 3 weeks after the last day of self-monitoring (window: 7 days)

  5. Change from quality of life

    Quality of life measured by the ECORTC QLQ C-30.

    Time frame: within 3 weeks after the last day of self-monitoring (window: 7 days)

  6. Change from symptoms

    Symptoms measured by the EORTC QLQ-OV28.

    Time frame: within 3 weeks after the last day of self-monitoring (window: 7 days)

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Feb 2025; primary completion for Jun 2025, 4 months later.

Of 284 non-industry interventional studies with no phase under Ovarian Neoplasms, half reached primary completion within 47 months of starting (the median), counting those still running; a quarter within 24 and three quarters within 76. This study's planned 4 months is below that.

Counting every sponsor, half of 295 studies reached it within 46 months; a quarter within 23 and three quarters within 76.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 2, 2025
First posted
Feb 6, 2025
StartEst.
Feb 2025
Primary completionEst.
Jun 2025
CompletionEst.
Jun 2025
Last update
Feb 6, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 6, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06813001
Lead sponsor
Yonsei University
Responsible party
Sponsor
First posted
Feb 6, 2025
Start date
Feb 2025 (estimated)
Primary completion
Jun 2025 (estimated)
Completion
Jun 2025 (estimated)
Last update
Feb 6, 2025

Study contacts

Jiyeon Lee, RN, NP, Ph.D
Contact
jiyeonest@yuhs.ac
82-2-2228-3255

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Feb 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion